Millie
your market intelligence analyst
Search Results
56 results
Your search is now limited to «Lung Cancer» expert search.
Clinical Features and Prognostic Factor of Thoracic Postoperative Oligo-Recurrence of Non-Small-Cell Lung Cancer Qi Yuan,1– 3 Wei Wang,1– 3 Qian Zhang,1– 3 Yuchao Wang,1– 3 Chuanzhen Chi,1– 3 Chunhua Xu1– 3 1Endoscopic Center of the Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, People’s Republic of China; 2Clinical Center of Nanjing Respiratory Diseases and Imaging, Nanjing, Jiangsu 210029, People’s Republic of China; 3Department of Respiratory Medicine, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, People’s Republic of ChinaCorrespondence: Chunhua XuDepartment of Respiratory Medicine, The Affiliated Brain Hospital of Nanjing Medical University, 215 Guangzhou Road,
Business Wire 02/24/2020 09:37
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502 / NYSE: TAK) heeft vandaag aangekondigd dat de Amerikaanse Food and Drug Administration (FDA) prioriteitsbeoordeling heeft verleend voor de aanvullende aanvraag voor nieuwe geneesmiddelen van het bedrijf (sNDA) om het gebruik van ALUNBRIG (brigatinib) uit te breiden als eerstelijnsbehandeling voor patiënten met anaplastisch lymfoom kinase-positieve (ALK +) metastatische non-small cell lung cancer.
Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients Anurag Mehta,1 Mumtaz Saifi,2 Ullas Batra,3 M Suryavanshi,2 Kush Gupta4 1Laboratory Services, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India; 2Department of Molecular Pathology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India; 3Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India; 4Catalyst Clinical Services, New Delhi, IndiaCorrespondence: Anurag MehtaLaboratory Services, Rajiv Gandhi Cancer Institute and Research Centre, Sector V, Rohini, New Delhi 110085 Tel +91 9868 020 371Email anumehta11@gmail.comBackground: The ROS1 gene is a member of

Information Technologies

IT Markets

Business Issues

Companies - Public

Companies - Venture Funded

Analysts

Analyst Firms

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications